2013 annual financial data
Avalo Therapeutics 2013 Financial results
Direct answer
Revenue was Not available.
Operating income was -12,934,448 USD and net income was -13,045,008 USD.
Operating cash flow was -11,485,140 USD.
Get free Avalo Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- Not available
- Operating income
- -12,934,448 USD
- Net income
- -13,045,008 USD
- Operating cash flow
- -11,485,140 USD
Explore related company data
View all 2013 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Net marginView Operating cash flow marginView all Avalo Therapeutics financial years